Knowledge bank grows as genome sequencing becomes mainstream

02/19/2013 | New York Times (tiered subscription model), The

As the price of sequencing the human genome has fallen, parents of children with undiagnosed or rare diseases have become more willing to have their children's genomes sequenced, thus adding to the available data on genetic mutations. Expectations are high, but the technology leads to beneficial treatment in only about 1% of patients.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park